Sökning: "lars johansson umeå"
Visar resultat 1 - 5 av 18 avhandlingar innehållade orden lars johansson umeå.
1. Risk markers and incidence of atrial fibrillation in northern Sweden
Sammanfattning : Background: Atrial fibrillation (AF) is the most common clinically significant arrythmia with a prevalence of approximately 3% in the general population. Less is known about the incidence of AF. In order to reduce the incidence of AF, it is of essence to identify modifiable risk factors for the disease. LÄS MER
2. Biomarkers and risk of intracerebral hemorrhage : population-based studies in northern Sweden
Sammanfattning : BackgroundIntracerebral hemorrhage (ICH) is a disease associated with a high morbidity and mortality and treatment options for the condition are limited. Even though an ICH event usually comes as a surprise to the affected individual, pathogenetic processes often have occurred before the sudden ICH event and may have preceded disease onset by years. LÄS MER
3. Epidemiology of venous thromboembolism with focus on risk markers
Sammanfattning : Background: Venous thromboembolism (VTE) is a vascular disease with an incidence of approximately 140 cases per 100,000 person-years in adults. The incidence of VTE has increased over the last decades, and more than 20% of affected individuals die in the first year after diagnosis. LÄS MER
4. Synderskan och lagen: Barnamord i tre Norrlandslän 1830-1870
Sammanfattning : ABSTRACTMany studies have been conducted on infanticide and child homicide. Researchers have approached the subject with different theoretical frameworks and explored it from different dimensions, geographical areas, and time periods. As much as the questions have varied so have the answers. LÄS MER
5. Strengthening lifestyle interventions in primary health care : the challenge of change and implementation of guidelines in clinical practice
Sammanfattning : Background: Lifestyle habits like tobacco use, hazardous use of alcohol, unhealthy eating habits and insufficient physical activity are risk factors for developing non-communicable diseases, which are the leading, global causes of death. Furthermore, ill health and chronic diseases are costly and put an increased burden on societies and health systems. LÄS MER